Via Oncology's Acquisition

Via Oncology was acquired by Elsevier on January 17, 2018.

Via Oncology is a provider of decision support and best practices recommendations for treating cancer. Via Oncology's clinical pathways, which were developed by cancer doctors at UPMC Hillman Cancer C…

Articles about Via Oncology's Acquisition: